{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["26(9)"],"submitter":["Milani R"],"pubmed_abstract":["Glioblastoma multiforme (GBM), a malignant tumor of the central nervous system, has a high mortality rate. No curative treatment is presently available, and the most commonly used chemotherapeutic drug, the alkylating agent temozolomide (TMZ), is only able to increase life expectancy and is often associated with drug resistance. Therefore, an urgent need does exist for novel drugs aimed at treating gliomas. In the present study, we obtained three major results using corilagin: (a) demonstrated that it inhibits the growth of U251 glioma cells through activation of the apoptotic pathway; (b) demonstrated that it is also active on TMZ-resistant T98G glioma cells; and (c) demonstrated that when used in combination with TMZ on T98G glioma cells, a higher level of proapototic and antiproliferati"],"journal":["Oncology research"],"pagination":["1307-1315"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7844640"],"repository":["biostudies-literature"],"pubmed_title":["Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line."],"pmcid":["PMC7844640"],"pubmed_authors":["Milani R","Marzaro G","Gambari R","Brognara E","Fabbri E","Lampronti I","Finotti A","Borgatti M","Kok SH","Chui CH","Chilin A","Lee KK"],"additional_accession":[]},"is_claimable":false,"name":"Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line.","description":"Glioblastoma multiforme (GBM), a malignant tumor of the central nervous system, has a high mortality rate. No curative treatment is presently available, and the most commonly used chemotherapeutic drug, the alkylating agent temozolomide (TMZ), is only able to increase life expectancy and is often associated with drug resistance. Therefore, an urgent need does exist for novel drugs aimed at treating gliomas. In the present study, we obtained three major results using corilagin: (a) demonstrated that it inhibits the growth of U251 glioma cells through activation of the apoptotic pathway; (b) demonstrated that it is also active on TMZ-resistant T98G glioma cells; and (c) demonstrated that when used in combination with TMZ on T98G glioma cells, a higher level of proapototic and antiproliferati","dates":{"release":"2018-01-01T00:00:00Z","publication":"2018 Oct","modification":"2025-06-01T01:54:42.031Z","creation":"2025-06-01T01:54:42.031Z"},"accession":"S-EPMC7844640","cross_references":{"pubmed":["28474573"],"doi":["10.3727/096504017X14928634401187"]}}